Intraoperative Quantitative Measurements for Bradykinesia Evaluation during Deep Brain Stimulation Surgery Using Leap

Jingchao Wu1, Ningbo Yu2,3, Yang Yu4

  • 1Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin 300350, China.

Parkinson'S Disease
|July 5, 2021
PubMed
Summary

The Leap Motion Controller (LMC) accurately quantifies bradykinesia in Parkinson's disease (PD) patients during deep brain stimulation (DBS) surgery. This technology enhances intraoperative assessment of motor function, improving treatment efficacy for PD.

Related Concept Videos